Company: NOTV
Filing Date: 2025-12-05
Form Type: 10-K
Source: 0001628280-25-055483
Chunk: 149

Company: Inotiv, Inc.
Filing Date: 2025-12-05
Form: 10-K
Item: Item 1
Chunk 149
---
 of products sold and excludes depreciation and amortization of intangible assets, which is separately stated2 Operating expenses include selling, general and administrative and other operating expenses and exclude depreciation and amortization of intangible assets, which is separately stated3 Table may not foot due to rounding

For the twelve months ended September 30, 2025, DSA revenue was $187,943 compared to $180,116 for the twelve months ended September 30, 2024, representing an increase of $7,827, or 4.3%. The increase in DSA revenue was primarily driven by a $6,376 increase in safety assessment services revenue as a result of an increase in biotherapeutic analysis revenue in connection with new business at our Rockville facility, an increase in surgical services revenue and an increase in general toxicology services revenue. The remaining increase in DSA revenue was primarily due to an increase in our discovery and translational science services revenue.

DSA operating income decreased by $415, or 4.8%, primarily due to an increase of $10,998 in cost of revenue, partially offset by the $7,827 increase in revenue noted above and a decrease of $2,870 in operating expenses. The increase in cost of revenue was primarily due to increases in compensation and benefits expense, partially as a result of additional commercial activity at our Rockville facility, research model expense, professional fees, repairs and maintenance expense and utilities expense, among other changes. The decrease in operating expenses primarily related to decreases in bad debt expense and professional fees, partially offset by an increase in compensation and benefits expense. 

47

RMS

Twelve Months EndedSeptember 30,20252024$ Change% ChangeRevenue$325,081$310,623$14,458 4.7 %Cost of revenue 1253,830252,3521,4780.6 %Operating expenses 213,39951,586(38,187)(74.0)%Depreciation and amortization of intangible assets37,24138,614(1,373)(3.6)%Operating income (loss) 3$20,611$(31,929)$52,540(164.6)%Operating income (loss) % of total revenue4.0 %(6.5)%Operating income (loss) % of segment revenue6.3 %(10.3)%1 Cost of revenue excludes depreciation and amortization of intangible assets, which is separately stated2 Operating expenses include selling, general